Patrick J. Curran
10Patents
4h-index
45Co-inventors
52Inventor score
Filing activity: Jun 2, 2003 → Jan 18, 2011
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7563798B2 | Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors | Human Necessities | 11 | Active |
| US8278337B2 | Substituted pyridines that are JNK inhibitors | Chemistry; Metallurgy | 8 | Active |
| US7576085B2 | Imidazopyrazines as cyclin dependent kinase inhibitors | Human Necessities | 8 | Active |
| US7511040B2 | Imidazopyrazines as protein kinase inhibitors | Human Necessities | 7 | Active |
| US7115749B2 | Substituted 5-oxo pyrazoles and [1,2,4]triazoles as antiviral agents | Chemistry; Metallurgy | 3 | Expired |
| US7196111B2 | Pyrazolo[1,5a]pyrimidine compounds as antiviral agents | Human Necessities | 3 | Expired |
| US7511063B2 | High affinity quinoline-based kinase ligands | Chemistry; Metallurgy | 0 | Active |
| US7446195B2 | High affinity thiophene-based and furan-based kinase ligands | Chemistry; Metallurgy | 0 | Active |
| US7425640B2 | Substituted 5-carboxyamide pyrazoles and [1,2,4]triazoles as antiviral agents | Chemistry; Metallurgy | 0 | Active |
| US9227971B2 | Pyrazolo[1,5-a]pyrimidine compounds as mTOR inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.